Clinical Research Directory
Browse clinical research sites, groups, and studies.
Liquid Biopsy for Hepatocellular Carcinoma Molecular Characterization After Y90
Sponsor: Palo Alto Veterans Institute for Research
Summary
The purpose of this study is to determine if baseline liquid biopsy assays (CTC and cf-DNA) as well as single circulating tumor cell-DNA (sCTC DNA) dynamics in the early post-treatment period can predict subsequent treatment response to Y-90 radioembolization in patients with hepatocellular carcinoma (HCC).
Official title: Liquid Biopsy for Hepatocellular Carcinoma Molecular Characterization and Assessment of Treatment Response After Y90 Radioembolization: A Pilot Study
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
12
Start Date
2024-08-01
Completion Date
2026-12-01
Last Updated
2025-12-26
Healthy Volunteers
No
Conditions
Locations (1)
VA Palo Alto Health Care System
Palo Alto, California, United States